Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 07 Jun 2024

Exploring the role of trifarotene against RAR-α: an investigation of expression pattern and clinicopathological significance of RAR-α in breast cancer

in Pharmacology of Anti-Cancer Drugs

Nusrat Jan
Shazia Sofi
Adel Abo Mansoor
Adil Abdelrahim
Irshad Ahmad
Abdullah Almilabairy
Fuzail Ahmad
Manzoor Ahmad Mir

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1361679

2,678 views
18 citations

Review

Published on 07 Jun 2024

Telomere-related DNA damage response pathways in cancer therapy: prospective targets

in Pharmacology of Anti-Cancer Drugs

Liting Gu
Mingdi Liu
Yuning Zhang
Honglan Zhou
Yishu Wang
Zhi-Xiang Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1379166

2,850 views
4 citations

Review

Published on 07 Jun 2024

To eat or not to eat: a critical review on the role of autophagy in prostate carcinogenesis and prostate cancer therapeutics

in Pharmacology of Anti-Cancer Drugs

Natalie Jayne Kurganovs
Nikolai Engedal

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1419806

2,732 views
3 citations

Original Research

Published on 06 Jun 2024

Pharmacokinetic evaluation of paclitaxel, albumin-binding paclitaxel, and liposomal-encapsulated albumin-binding paclitaxel upon gastric subserosal administration

in Pharmacology of Anti-Cancer Drugs

Yoontaek Lee
Sun Mi Park
In Ho Song
Bom Sahn Kim
Hyun Soo Park
Byung Seok Moon
Hyung-Ho Kim

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1381406

1,842 views
4 citations

Original Research

Published on 05 Jun 2024

IL-23 inhibitor enhances the effects of PTEN DNA-loaded lipid nanoparticles for metastatic CRPC therapy

in Pharmacology of Anti-Cancer Drugs

Xinlu Chen
Luyao Gong
Yuanyuan Wang
Chen Ye
Huanhuan Guo
Shen Gao
Jiyuan Chen
Zhuo Wang
Yuan Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1388613

2,258 views

Editorial

Published on 05 Jun 2024

Editorial: Gliomas microenvironment: new drug entities, mechanisms of action, molecular biomarkers and drug delivery strategies

in Pharmacology of Anti-Cancer Drugs

Mariana Magalhães
Diana Matias
Claudia Carbone
Célia Cabral

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1431975

890 views

Original Research

Published on 04 Jun 2024

Identification of potential novel N6-methyladenosine effector-related lncRNA biomarkers for serous ovarian carcinoma: a machine learning-based exploration in the framework of 3P medicine

in Pharmacology of Anti-Cancer Drugs

Lele Ye
Xinya Tong
Kan Pan
Xinyu Shi
Binbing Xu
Xuyang Yao
Linpei Zhuo
Su Fang
Sangsang Tang
Zhuofeng Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1351929

2,584 views
3 citations

Systematic Review

Published on 04 Jun 2024

Concomitant use of renin-angiotensin system inhibitors augments the efficacy of immune checkpoint inhibitors: a systematic review and meta-analysis

in Pharmacology of Anti-Cancer Drugs

Junjie Yu
Fangang Meng
Wenxia Sui
Junmin Yu
Jinhai Shen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1378577

1,323 views
4 citations

Original Research

Published on 04 Jun 2024

Crebanine, an aporphine alkaloid, induces cancer cell apoptosis through PI3K-Akt pathway in glioblastoma multiforme

in Pharmacology of Anti-Cancer Drugs

Poh-Shiow Yeh
Chien-Te Liu
Chia-Ying Yu
Ya-Chuan Chang
Shu-Yu Lin
Yun-Chen Li
Yu-Ze Luan
Wen-Wei Sung

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1419044

2,084 views
4 citations

Review

Published on 04 Jun 2024

Traditional Chinese medicine for acute myelocytic leukemia therapy: exploiting epigenetic targets

in Pharmacology of Anti-Cancer Drugs

Xinlong Gao
Xu Zuo
Tianjiao Min
Yu Wan
Ying He
Beier Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1388903

5,097 views
4 citations

Review

Published on 04 Jun 2024

Advancing perspectives on the off-label use of anticancer drugs: an updated classification and exploration of categories

in Pharmacology of Anti-Cancer Drugs

Xiaoyi Chen
Shunlong Ou
Jing Luo
Zhisan He
Qian Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1374549

1,919 views

Original Research

Published on 03 Jun 2024

Chemokine ligand 14 correlates with immune cell infiltration in the gastric cancer microenvironment in predicting unfavorable prognosis

in Pharmacology of Anti-Cancer Drugs

Bing Lu
Jiawen Shi
Tong Cheng
Congshuo Wang
Manyu Xu
Pingping Sun
Xiaojing Zhang
Lei Yang
Peng Li
Han Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1397656

2,113 views
2 citations

Original Research

Published on 31 May 2024

Integrated pan-cancer analysis reveals the immunological and prognostic potential of RBFOX2 in human tumors

in Pharmacology of Anti-Cancer Drugs

Fengxian Huang
Long Jin
Xinyue Zhang
Min Wang
Congya Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1302134

2,826 views
3 citations

Original Research

Published on 31 May 2024

Proteomic profiling and biomarker discovery for predicting the response to PD-1 inhibitor immunotherapy in gastric cancer patients

in Pharmacology of Anti-Cancer Drugs

Jiangang Sun
Xiaojing Li
Qian Wang
Peng Chen
Longfei Zhao
Yongshun Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1349459

3,528 views
3 citations

Original Research

Published on 30 May 2024

IL4I1: a novel molecular biomarker represents an inflamed tumor microenvironment and precisely predicts the molecular subtype and immunotherapy response of bladder cancer

in Pharmacology of Anti-Cancer Drugs

Xiangrong Peng
Chuan Liu
Li Zhang
Yin Chen
Lixin Mao
Shenglin Gao
Xiaokai Shi
Li Zuo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1365683

4,077 views
2 citations

Review

Published on 30 May 2024

Bi-specific T-cell engagers (BiTEs) in prostate cancer and strategies to enhance development: hope for a BiTE-r future

in Pharmacology of Anti-Cancer Drugs

Harriet Lampe
Laura Tam
Aaron R. Hansen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1399802

6,471 views
8 citations